NYSE$PHR

Phreesia Inc · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

Phreesia announced financial results for the fiscal first quarter ended April 30, 2023.

Phreesia's total revenue was $83.8 million, a 32% increase compared to the same period last year. The average number of healthcare services clients increased by 31%, while net loss decreased from $51.2 million to $37.5 million.

  • Total revenue increased by 32% to $83.8 million compared to the same period in the prior year.
  • The average number of healthcare services clients increased by 31% to 3,309.
  • Net loss decreased to $37.5 million compared to $51.2 million in the same period in the prior year.
  • Adjusted EBITDA was negative $13.8 million compared to negative $30.6 million in the same period in the prior year.

Headline financials

Total Revenue

$83.8M

Previous: $63.4M+32.3%
EPS (adj)

-$0.70

Previous: -$0.99+29.3%
Revenue per AHSC

$25.3K

No prior period
Patient Payment Volume

$1.02B

Previous: $837M+21.4%
Payment Facilitator % Volume

82.0%

Previous: 80.0%+2.5%
Capital Expenditures

-$1.35M

Previous: -$1.79M+24.5%
Free Cash Flow

-$38.9M

Previous: -$53M+26.7%
Net Income

-$37.5M

Previous: -$51.2M+26.8%
Operating Income

-$37.9M

Previous: -$50.6M+25.1%
Gross Profit

$68.9M

Previous: $49M+40.8%
Cash & Equivalents

$150M

Previous: $269M-44.4%
Total Assets

$354M

Previous: $459M-22.9%
Stock-Based Comp

$17.1M

Previous: $14.2M+21.1%

Revenue & EPS history

Phreesia · Revenue · Quarterly

$83.8M

Q1 2024+32.3%vs Q1 2023
Beat estimate in 11 of 15 quarters(73%)
ActualEstimate

Revenue by segment

Phreesia · $83.8M total across 3 segments · Q1 2024

  • Subscription Services
    $37.9M+30.2%
  • Payment Processing
    $24.3M+25.1%
  • Network Solutions
    $21.7M

Forward guidance

For the full fiscal year 2024 ending January 31, 2024, Phreesia expects revenue to be between $353 million and $356 million, implying year-over-year growth of 26% to 27%. Adjusted EBITDA outlook for fiscal year 2024 is raised to a range of negative $60 million and negative $55 million from a previous range of negative $65 million to negative $60 million.

Tailwinds

  • Revenue expected to be between $353 million and $356 million for fiscal year 2024.
  • Year-over-year revenue growth of 26% to 27% is expected.
  • Adjusted EBITDA outlook for fiscal year 2024 raised to a range of negative $60 million and negative $55 million.
  • Strong performance in the first quarter contributed to the raised Adjusted EBITDA outlook.
  • Maintaining $500 million revenue target to be achieved by annualizing our highest-revenue quarter in fiscal year 2025.

Headwinds

  • Adjusted EBITDA outlook for fiscal year 2024 remains negative.
  • Uncertainty and potential variability of Other (income) expense, net.
  • Uncertainty and potential variability of (Benefit from) provision for income taxes.
  • Reconciliation of the non-GAAP financial measure outlook to the corresponding GAAP measure is not available without unreasonable effort.
  • Items could have a significant impact on the calculation of GAAP Net income (loss).

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

-1.6%

Avg return

Earnings day

+2.5%

Avg return

5 days after

+2.0%

Avg return

30 days after

54%

15 / 28 earnings

Positive

+21.4%

Q2 2023

Best reaction

-26.3%

Q4 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-26.3%-1.1%
Q1 2027+2.3%+13.3%
Q3 2026-22.8%-19.2%-16.0%
Q2 2026-9.8%-18.8%-25.4%
Q1 2026-6.6%-0.2%+14.2%
Q4 2025+6.9%+14.6%+1.1%
Q3 2025+11.1%+14.8%+30.8%
Q2 2025+7.9%+0.5%-6.8%
Q1 2025-13.3%-14.7%-2.9%
Q4 2024+1.7%-0.7%+1.0%
Q3 2024+17.8%+18.8%+45.2%
Q2 2024-21.2%-27.1%-39.1%
Q1 2024+3.6%+10.3%+4.0%
Q4 2023-13.5%-10.0%-5.7%
Q3 2023+18.7%+34.8%+20.0%
Q2 2023+21.4%+28.2%+4.9%
Q1 2023+11.9%+17.5%+40.1%
Q4 2022-11.9%+1.3%-23.6%
Q3 2022-20.2%-20.9%-32.9%
Q2 2022-12.4%-6.2%-15.4%
Q1 2022+6.6%+12.7%+24.2%
Q4 2021+2.5%+8.4%+3.3%
Q3 2021+7.3%+18.1%+16.2%
Q2 2021-3.2%-9.2%+3.5%
Q1 2021-6.7%-10.5%-13.1%
Q4 2020+4.2%+18.1%+30.6%
Q3 2020-1.0%-8.8%-6.9%
Q2 2020+0.2%+7.3%+1.2%
Q1 2020
Q4 2019
Q3 2018
Q2 2018
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro